{"id":2391,"date":"2016-04-01T12:00:00","date_gmt":"2016-04-01T10:00:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2016\/behandlung-von-schlaflosigkeit-im-alter"},"modified":"2016-04-01T12:00:00","modified_gmt":"2016-04-01T10:00:00","slug":"behandlung-von-schlaflosigkeit-im-alter","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2016\/behandlung-von-schlaflosigkeit-im-alter","title":{"rendered":"Behandlung von Schlaflosigkeit im Alter"},"content":{"rendered":"<p>Zusammenfassung: Schlaflosigkeit (Insomnie) ist im Alter ein sehr h\u00e4ufiges Problem, und gerade \u00e4ltere Menschen werden deswegen vorwiegend medikament\u00f6s behandelt. Nicht-medikament\u00f6se Behandlungsoptionen, wie z.B. kognitive Verhaltenstherapie, sind ebenfalls wirksam, werden aber wenig genutzt. Typische &#8222;Schlafmittel&#8220; (meist Agonisten des Benzodiazepinrezeptors) und andere sedierende Pharmaka sollten bei alten Menschen wegen des ung\u00fcnstigen Verh\u00e4ltnisses von Nutzen und Risiken prinzipiell [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zusammenfassung: Schlaflosigkeit (Insomnie) ist im Alter ein sehr h\u00e4ufiges Problem, und gerade \u00e4ltere Menschen werden deswegen vorwiegend medikament\u00f6s behandelt. Nicht-medikament\u00f6se Behandlungsoptionen, wie z.B. kognitive Verhaltenstherapie, sind ebenfalls wirksam, werden aber wenig genutzt. Typische &#8222;Schlafmittel&#8220; (meist Agonisten des Benzodiazepinrezeptors) und andere sedierende Pharmaka sollten bei alten Menschen wegen des ung\u00fcnstigen Verh\u00e4ltnisses von Nutzen und Risiken prinzipiell [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[918,912,1120,600,2408,10,914,994,3876,3877,4736,11,1242,4740,4739,1249,2424,3878,4738,652,2901,2190,2430,2065,4741,4737,4742,905,3476,4734,3477,2405,756,899,4733,4735,906,898,908],"class_list":["post-2391","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-antihistaminika","tag-antipsychotika","tag-baldrian","tag-benzodiazepine","tag-brotizolam","tag-diazepam","tag-diphenhydramin","tag-doxepin","tag-durchschlafstoerungen","tag-einschlafstoerungen","tag-estazolam","tag-flunitrazepam","tag-flurazepam","tag-hopfenextrakt","tag-kognitive-verhaltenstherapie","tag-lorazepam","tag-lormetazepam","tag-melatonin","tag-melisse","tag-melperon","tag-midazolam","tag-mirtazapin","tag-nitrazepam","tag-opipramol","tag-passionsblume","tag-pipamperon","tag-prothipendyl","tag-quetiapin","tag-schlaflosigkeit","tag-schlafmittel","tag-schlafstoerungen","tag-temazepam","tag-trazodon","tag-triazolam","tag-verhaltenstherapie","tag-z-substanzen","tag-zaleplon","tag-zolpidem","tag-zopiclon"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2391","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2391"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2391\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2391"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2391"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2391"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}